Results 141 to 150 of about 7,326 (212)

Induction of immunogenic necroptosis by shikonin in drug‑resistant head and neck squamous cell carcinoma cells. [PDF]

Oncol Rep
Kishita S, Umemura N, Miyazaki H, Adachi M, Yagi H, Ohkoshi E.   +5 more
europepmc   +1 more source

Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression. [PDF]

Front Pharmacol
Liu W, Liu Q, Yao J, Wu D, Li W, Fu Z, Zhao M, Liang Y.   +7 more
europepmc   +1 more source

Shikonin inhibits multiple tumor malignant phenotypes and is associated with Hedgehog pathway downregulation in lung adenocarcinoma. [PDF]

Sci Rep
Wang HG, Lu MX, Sheng ML, Lou YB, Xiao YC, Guo A, Yu ZH.   +6 more
europepmc   +1 more source

Oral delivery of dextran-modified albumin nanoparticles loaded with shikonin for targeted therapy of colorectal cancer. [PDF]

Discov Nano
Ren Z, Zhao J, Li S, Hong Y.
europepmc   +1 more source

Palmatine inhibits TRIF-dependent NF-kB pathway against inflammation induced by LPS in goat endometrial epithelial cells [PDF]

, 2017
Cheng, Z R, Dong, S, Na, L, Sang, M, Wang, D, Yan, B, Yan, Z, Yang, H, Yang, Z, Zhang, S   +9 more
core  

A Review of the Main Biologically Active Compounds of the Genus <i>Echium</i> L., Naturally Distributed in Bulgaria, and Their Pharmacological Potential. [PDF]

Pharmaceuticals (Basel)
Terzieva S, Grozeva N, Tzanova M.
europepmc   +1 more source

M2 macrophages promote lymphatic metastasis by regulating PKM2 nuclear translocation in triple-negative breast cancer. [PDF]

Cell Death Dis
Yang Y, Ye H, Zhong D, Gao J, Yu M, Chen L, Zhou R, Zhang L, Cong Y, Qiao Z, Guan L, Mao Y, Li Z, Tian W, Zhao B, Zhao H.   +15 more
europepmc   +1 more source

A meta-analysis of the traditional herb Zicao and its active components for atopic dermatitis. [PDF]

Front Pharmacol
Wu QY, Jiang YY, Ming JE, Hao PS.
europepmc   +1 more source

Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma. [PDF]

Front Pharmacol
Jia R, Liang Y, Zou B, Li X, Chen T, Zhang C, Bian J, Guo R.   +7 more
europepmc   +1 more source

Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective. [PDF]

Front Pharmacol
Pandey P, Lakhanpal S, Jamuna KV, Singh A, Abohassan M, Park MN, Shin SW, Kang HN, Zahera M, Saeed M, Khan F, Kim B.   +11 more
europepmc   +1 more source